| Literature DB >> 32863525 |
Nicholas W Kreofsky1, Maxwell D Dillenburg1, Eric M Villa1, James T Fletcher1.
Abstract
Bidentate chelators 1-(1-benzyl-1,2,3-triazol-4-yl)isoquinoline and 3-(1-benzyl-1,2,3-triazol-4-yl)isoquinoline were prepared from benzyl bromide and trimethylsilylethynylisoquinoline precursors using a tandem deprotection/substitution/CuAAC synthetic approach. Each chelator is capable of forming a stable 3:1 Ru(II) coordination compound, which forms as a geometric isomer mixture. These Ru(II) complexes possess unique MLCT absorbance signatures at 450/472 nm (1-isomer) and 367 nm (3-isomer) relative to their constituent chelating units. Minimum inhibitory concentration values as low as 0.4 μM are observed for Ru(II) complexes against representative Gram-positive bacteria Bacillus subtilis and Staphylococcus epidermidis. Comparing the MIC values of these isoquinoline compounds with analogous 2-(1-benzyl-1,2,3-triazol-4-yl)pyridine compounds shows a 2.5- to 40-fold improvement in potency. This study establishes that increased hydrophobicity introduced at the central chelating units of Ru(II) coordination compounds can be a useful means by which to optimize antimicrobial activity that is complimentary to the variation of peripheral substituent identity at the chelator's N1 triazole position.Entities:
Keywords: 1,2,3-Triazole; Antibacterial; Bidentate chelator; Coordination compound; Tandem synthesis
Year: 2019 PMID: 32863525 PMCID: PMC7453797 DOI: 10.1016/j.poly.2019.114259
Source DB: PubMed Journal: Polyhedron ISSN: 0277-5387 Impact factor: 3.052